Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 28, 2016; 22(24): 5459-5466
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5459
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5459
Table 1 A comparison of clinic-pathological data between type-B and type-C hepatocellular carcinoma
| Type B (n = 97) | Type C (n = 81) | P value | |
| Age (yr) | 56.1 ± 11.9 | 66.7 ± 9.8 | < 0.0001 |
| Sex (M:F) | 71.1%:28.9% | 60.5%:39.5% | 0.18 |
| AST (IU/L) | 82.2 ± 98.6 | 81.8 ± 44.1 | 0.18 |
| ALT (IU/L) | 67.7 ± 70.9 | 83.2 ± 56.9 | 0.11 |
| T.Bil (mg/dL) | 1.2 ± 1.1 | 1.0 ± 0.6 | 0.36 |
| Alb (g/dL) | 4.0 ± 0.6 | 3.9 ± 0.5 | 0.22 |
| Plt (/mm3) | 13.9 ± 8.1 | 10.8 ± 5.5 | < 0.005 |
| Histology | |||
| F1:2:3:4 | 2:20:3:32 | 1:6:8:21 | < 0.005 |
| A1:2:3 | 17:25:12 | 1:14:17 | < 0.005 |
| Clinical stage (I:II:III:IV) | 12:29:25:31 | 15:32:29:5 | < 0.0005 |
- Citation: Ohkoshi S, Hirono H, Watanabe K, Hasegawa K, Kamimura K, Yano M. Natural regression of fibrosis in chronic hepatitis B. World J Gastroenterol 2016; 22(24): 5459-5466
- URL: https://www.wjgnet.com/1007-9327/full/v22/i24/5459.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i24.5459